NCT06568263 Celiac Disease and Quality of Life in Children and Adolescents (CeliaQLife)
| NCT ID | NCT06568263 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Oslo University Hospital |
| Condition | Celiac Disease in Children |
| Study Type | OBSERVATIONAL |
| Enrollment | 160 participants |
| Start Date | 2024-08-12 |
| Primary Completion | 2025-12-20 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 160 participants in total. It began in 2024-08-12 with a primary completion date of 2025-12-20.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Celiac disease is a disorder commonly diagnosed during childhood. The treatment is a lifelong gluten-free diet. Both the condition and the diet can influence the children's physical and emotional well-being. The main goal of this observational study is to learn about nutritional status in a group of children with celiac disease compared to a group of healthy children. The nutritional assessment includes information on diet, biochemical measurement, and body composition. Quality of life will also be assessed. The study can contribute to ensure good health and well-being in children on a gluten-free diet.
Eligibility Criteria
Inclusion Criteria: * eating a regular diet Exclusion Criteria: \-
Contact & Investigator
Janne A Kvammen, Phd
PRINCIPAL INVESTIGATOR
Oslo University Hospital
Frequently Asked Questions
Who can join the NCT06568263 clinical trial?
This trial is open to participants of all sexes, aged 6 Years or older, up to 18 Years, studying Celiac Disease in Children. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06568263 currently recruiting?
Yes, NCT06568263 is actively recruiting participants. Contact the research team at cathrine.strandskogen@medisin.uio.no for enrollment information.
Where is the NCT06568263 trial being conducted?
This trial is being conducted at Oslo, Norway, Oslo, Norway.
Who is sponsoring the NCT06568263 clinical trial?
NCT06568263 is sponsored by Oslo University Hospital. The principal investigator is Janne A Kvammen, Phd at Oslo University Hospital. The trial plans to enroll 160 participants.